Want to see KR:063160 full AI Analyst Report?
CKD Bio Corp. (063160) Financial Statements
CKD Bio Corp. Financial Overview
CKD Bio Corp.'s market cap is currently $67.64B. The company's EPS TTM is $-1957.79; its P/E ratio is -6.30; and it has a dividend yield of 0.46%. CKD Bio Corp. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 160.07B | $ 171.76B | $ 160.35B | $ 156.04B | $ 142.24B |
| Gross Profit | $ 26.10B | $ 35.94B | $ 5.01B | $ 16.79B | $ 13.31B |
| Operating Income | $ 3.61B | $ 10.95B | $ -20.15B | $ -14.77B | $ -9.81B |
| EBITDA | $ 19.26B | $ 31.17B | $ -1.63B | $ 2.29B | $ 5.56B |
| Net Income | $ -2.89B | $ 8.70B | $ -24.19B | $ -16.70B | $ -6.58B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.50B | $ 1.16B | $ 3.70B | $ 12.72B | $ 3.53B |
| Total Assets | $ 299.87B | $ 284.49B | $ 293.79B | $ 312.59B | $ 298.54B |
| Total Debt | $ 144.96B | $ 131.21B | $ 146.93B | $ 138.93B | $ 109.38B |
| Net Debt | $ 143.53B | $ 130.11B | $ 143.30B | $ 134.27B | $ 105.91B |
| Total Liabilities | $ 172.83B | $ 153.48B | $ 170.76B | $ 164.79B | $ 137.05B |
| Stockholders' Equity | $ 127.04B | $ 131.01B | $ 123.02B | $ 147.80B | $ 161.49B |
| Cash Flow | |||||
| Free Cash Flow | $ -10.95B | $ 9.75B | $ -18.00B | $ -10.43B | $ -26.59B |
| Operating Cash Flow | $ -4.14B | $ 14.03B | $ -7.22B | $ -3.20B | $ -5.88B |
| Investing Cash Flow | $ -6.96B | $ -4.75B | $ -1.20B | $ -20.55B | $ -20.39B |
| Financing Cash Flow | $ 11.45B | $ -11.81B | $ 7.40B | $ 24.96B | $ 28.27B |
Currency in KRW